Allscripts announces first quarter 2018 results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Allscripts (MDRX) PT Lowered to $14.50 at RBC Capital
May 4, 2018 8:20 AM EDTRBC Capital lowered its price target on Allscripts (NASDAQ: MDRX) to $14.50 (from $17.00) while maintaining a Outperform rating.
... MoreAllscripts (MDRX) PT Lowered to $13 at Evercore ISI
May 4, 2018 7:44 AM EDTEvercore ISI lowered its price target on Allscripts (NASDAQ: MDRX) to $13.00 (from $14.00) while maintaining a Outperform rating.
... MoreAllscripts (MDRX) Misses Q1 EPS by 1c, Affirms Outlook
May 3, 2018 4:04 PM EDTAllscripts (NASDAQ: MDRX) reported Q1 EPS of $0.16, $0.01 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $518.6 million versus the consensus estimate of $530.48 million.
Allscripts affirms the following financial outlook for 2018
For earnings history and earnings-related data on Allscripts (MDRX) click here.
... More